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The adult respiratory distress syndrome (ARDS) represents a common denominator of acute
lung injury leading to alveolar flooding, decreased lung compliance, and altered gas transport. In
the absence of specific etiology and therapy, the management of ARDS remains largely
supportive. Ubiquitous use of intermittent positive-pressure ventilation with positive end-
expiratory pressure (PEEP) improves arterial oxygenation but with some risk of pulmonary
barotrauma and decreased cardiac output. The recent understanding of lung inflation as a
modulator of right heart afterload and the effect of the right ventricle on global cardiac
performance continues to redefine optimal patterns ofventilatory and hemodynamic intervention
in ARDS.
INTRODUCTION
Diffuse lung injury associated with shock or trauma has been recognized since the
early part ofthis century. The term, the adult respiratory distress syndrome (ARDS),
was defined by Petty and Ashbaugh [1] as acute, life-threatening respiratory failure
after widely diverse insults in patients with no prior history of cardiopulmonary
dysfunction. Although predisposing factors are usually multiple and diverse (Table 1)
[2-16], the pulmonary response to insult is stereotypic. While the precise pathogenic
mechanisms remain unknown, the common denominator of injury is damage to the
alveolar endothelium and epithelium, leading to increased permeability to protein,
interstitial and alveolar edema, and resultant impairment of gas transport [17,18].
This review will emphasize ventilatory and hemodynamic management of patients
with ARDS. The pathophysiology ofthis syndrome is also discussed.
DEFINITION
The diagnosis of ARDS should be made in accordance with criteria (Table 2) that
distinguish it from cardiogenic pulmonary edema or other forms of less severe
non-cardiogenic edema [19]. The syndrome is characterized by tachypnea, dyspnea,
and cyanosis in the context ofan antecedent catastrophic traumatic or systemic insult.
Chest radiographic features usually include an initial pattern of interstitial edema
followed by a later phase of diffuse alveolar infiltration and consolidation. Since it is
difficult to differentiate clinically between cardiogenic and noncardiogenic pulmonary
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TABLE 1
Predisposing Conditions for the Adult
Respiratory Distress Syndrome
Aspiration
pH > 2.5
pH < 2.5
Blood transfusion
Leukoagglutinin reaction
Microemboli
Burns (body surface)
Cardiopulmonary bypass
DIC
Drugs (idiosyncratic)
Thiazides
Drowning
Drug overdoses
Aspirin
Heroin
Methadone
Paraquat
Embolism
Fat
Pulmonary
Gas inhalation
Cl2
NH3
NO2
S02
Head injury
Hemodialysis
High altitude
Lung contusion
Myocardial failure (?)
Myocardial infarction (?)
Oxygen toxicity
Pancreatitis
Pneumonia
Gram-positive
Gram-negative
Legionella
Mycoplasma
Pneumocystis
Tuberculosis
Viral
Radiation
Re-expansion (lung)
Shock
Hemorrhagic
Sepsis
Smoke inhalation
TTP
Tumor lysis syndrome
(lymphoblastic leukemia)
Venous air embolism
edema, a Swan Ganz catheter is usually necessary. Physiologic manifestations of
ARDS include ventilation/perfusion (VA/Q) mismatch, right to left intrapulmonary
shunting, reduced functional residual capacity, and decreased total lung compliance,
resulting in arterial hypoxemia and altered gas transport across alveolar-capillary
membranes. The pulmonary edema and atelectasis result in pulmonary venous
admixture that may approach 50 percent oftotal cardiac output. Totalventilated dead
space increases and dead space to tidal volume (VD/VT) ratios may approach .6 or
greater.
In the early phases, the histology of ARDS consists of non-homogeneous areas of
atelectasis, alveolar flooding, hemorrhage, congestion, and inflammation [2]. The
lungs are wet and have an increased density, with the cut surface approaching the
texture of liver (Fig. 1). The gravity-dependent areas of the lung tend to be most
affected, but the lesions are spotty owing to the maldistribution of pulmonary blood
flow at the level ofthe microcirculation. After three to four days from the onset ofthe
clinical syndrome, hyaline membranes form in the air spaces from protein-rich fluid,
fibrin, and fibrinogen, and, after five to seven days, collagen deposition and fibrosis of
the lung occur [2].
Despite maximal pharmacological and mechanical support, including hemodynamic
and extracorporeal methods [20] to optimize systemic oxygen transport, mortality
rates in patients with ARDS remain greater than 50 percent. Data from the National
576THE ADULT RESPIRATORY DISTRESS SYNDROME
TABLE 2
Criteria for the Diagnosis of the Adult
Respiratory Distress Syndrome
A. Clinical setting
1. Catastrophic event
a. Pulmonary
b. Non-pulmonary, e.g., shock
2. Exclusions
a. Chronic pulmonary disease
b. Left heart dysfunction
3. Respiratory distress
a. Tachypnea 20 (b/m)
b. Labored breathing
B. X-ray: Diffuse pulmonary infiltration
1. Interstitial (early)
2. Alveolar (late)
C. Physiologic
1. PaO2 < 50 mm Hg with FIO2 > .6
2. Overall compliance, <50 cc/cm H20 (usually 20-30 cc/
cm H20)
3. Increased shunt function (Qs/Q,)
4. Increased dead space ventilation (VD/VT)
D. Pathologic
1. Heavy lungs, usually greater than 1,000 g
2. Congestive atelectasis
3. Hyaline membranes
4. Fibrosis
Reproduced with permission from [191.
Heart, Lung, and Blood Institute [21] demonstrated a mortality rate of 41 percent
among patients less than 65 years. Among thosepatients with acuterespiratory failure
and age greater than 65 years, the mortality rate was 68 percent. Further increases in
mortality wereobserved inpatients with ARDS in association withmulti-organ system
failure (Fig. 2).
FIG. 1. Cut
surface of post-
mortem ARDS
lung. Note exten-
sive consolida-
tion, with cut sur-
face approaching
the texture of
liver.
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PATHOPHYSIOLOGY OF ARDS
Alveolar-Capillary Permeability
The basic features of ARDS involve the development of excess fluid in the lungs in
the presence oflow or normal pulmonary capillary wedge pressures (PCWP). Principal
factors governing fluid (Q,) and solute (Q5) transfer from the alveolar capillary to the
pulmonary interstitium are net transmembrane hydrostatic pressure and net trans-
membrane oncotic pressure. Starling's equation [22] for transcapillary equilibrium
may be applied to the pulmonary microcirculation:
Q,= k[(P,, - Pj) -6(ir, -x,j)
where Qt = net flow rate across pulmonary capillary membrane
k = filtration coefficient
6 = reflection coefficient
Ppc = hydrostatic forces in pulmonary capillary
Ppi = hydrostatic forces in pulmonary interstitium
=rpC colloid osmotic pressure in pulmonary capillary
rpi colloid osmotic pressure in pulmonary interstitium
In the case of high-pressure, cardiogenic pulmonary edema, Qt into the pulmonary
interstitium is a function ofincreased pulmonary artery and venous hydrostatic forces.
In the case of low-pressure, non-cardiogenic pulmonary edema, endothelial damage
decreases the protein reflection coefficient, 6, and fluid and protein flow along a
positive pressure gradient into the pulmonary interstitium (interstitial pressure =-2
cm H20) [23,24] initially in a peribronchial and perivascular distribution.
The alveolar epithelium, in the normal lung with an intact basement membrane, has
high fluid (k) and solute (3) reflection coefficients [25-28]. This accounts for the
relative impermeability of the alveolus to extravascular lung water and the preserva-
tion of alveolar-capillary oxygen diffusion until alveolar flooding occurs. Pulmonary
edema does not usually occur unless the rate of fluid transfer into the pulmonary
interstitium exceeds maximal lung lymph clearance ratesof20ml/hour [14]. This rate
of edema formation correlates with PCWP greater than 26 mm Hg in normals.
Interstitial edema alone causes minimal gas exchange abnormalities, but with
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progressive alveolar flooding, oxygenation deteriorates. In fact, one recent experimen-
tal study showed a good correlation between worsening shunt fraction and a
progressive increase in extravascular lung water [28].
Clinical studies have confirmed that extravascular lung water is higher in patients
with ARDS than patients with cardiogenic pulmonary edema, presumably because of
an abnormal increase in endothelial and epithelial permeability (Fig. 3) [27].
Alveolar Gas Exchange
The mechanisms by which gas exchange abnormalities develop in ARDS are
complex. Increased lung endothelial permeability leads first to interstitial edema in a
peribronchial and perivascular distribution, followed by alveolar flooding. In terms of
lung mechanics, this process leads to increases in airway resistance, due to peribron-
chial edema, and decreased lung elastic properties, due to interstitial and alveolar
edema. This effect is manifested in practical terms as decreased lung compliance,
which is the change in volume per unit change in distending airway pressure of the
lung. As a result of the changes in the mechanical properties ofthe lung, a higher work
of breathing is required to generate adequate transpulmonary pressure to inflate the
lung. Ifthis increased work of breathing cannot be maintained, lung volume is reduced
as transpulmonary distending pressures do not exceed elastic recoil forces of the
alveoli. The volume at which alveolar forces favor airway closure is called the critical
closing volume, and similarly the pressure at which intra-alveolar pressure exactly
equals the pressure caused by the elastic recoil forces is called the critical closing
pressure. ARDS, therefore, results in a restrictive ventilatory pattern with a reduction
of total lung capacity (Fig. 4). Since alveolar collapse is most likely to occur at end
tidal breathing, ARDS produces a net reduction in functional residual capacity.
Early in the progression of altered membrane permeability in ARDS, the distribu-
tion of interstitial and alveolar lung water is not homogeneous. As a result, there is a
maldistribution of whole lung ventilation with inspired gas flow favoring alveoli with
normal compliance as opposed to those with collapse and decreased compliance. Gas
distribution throughout the lung is governed by airway time constants, which are a
product of airway resistance and segmental lung compliance.
Alveolar gas tensions, therefore, represent a balance between inspired gas distribu-
tion, alveolar-capillary membrane transfer, and uptake by the pulmonary circulation.
Under normal conditions, ventilation/perfusion ratios (VA/Q) are matched except for
gravitational differences in pulmonary blood flow (increasing from apex to base in the
upright position). VA/Q ratios can, however, range from zero in cases in which lung is
perfused but not ventilated (basilar lung) to infinity in segments of lung which are
ventilated and not perfused (apical lung). To take extreme conditions, a segment of
lung with a VA/Q = 0 would imply that blood flow is entering at mixed venous oxygen
and carbon dioxide contents and exits from the alveolar capillary unit without
alteration. This would represent shunted blood, and the ratio of shunted blood (Qs) to
total blood flow (Qt) would be the intrapulmonary shunt fraction (Q/Qt). Alterna-
tively, there may be ventilation but no perfusion, and in such an instance inspired gas
concentrations equal expired gas concentrations; this is referred to as dead space
ventilation, and the fraction of dead space ventilation (VD) to total ventilation (VT)
would be the dead space to tidal volume ratio (VD! VT). In one recent study of ARDS
patients, 32 percent of pulmonary blood flow was shunt, 17 percent was to low VA/Q
areas, and 40 percent to normal lung [29].
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FIG. 3. A. Analysis of repeated studies of patients demonstrated linear correlation between changes in
both PCWP and EXTLW in patients with, potentially, only hydrostatic influence on EXTLW formation.
Patients without radiographically determined edema (solidcircles) and cardiogenic pulmonary edema (open
circles) were assumed to reflect combined hydrostatic group. B. Analysis ofrepeated studies ofpatients
also demonstrated linear correlation between changes in both PCWP and EXTLW in patients with
non-cardiogenic pulmonary edema; importantly, the slope ofthis relationship was greater than found in the
hydrostatic group, A, indicating that changes in PCWP were accompanied by greater change in EXTLW
content in patients with non-cardiogenic pulmonary edema than occurred in patients classified in the
hydrostatic group. Reproduced with permission from [27].
Bronchoalveolar Lavage Characteristics
Analysis of bronchoscopic alveolar lavage specimens from ARDS patients yields a
variety ofinflammatory, vasoactive, and proteolytic mediators [2,30]. Lavage samples
are exudative, with protein concentrations equal to that of plasma. There is a rich
fraction of polymorphonuclear leukocytes (PMNs), oxidants, and proteases with the
ability to cleave complement [31], fibrinogen, fibronectin, plasma kallikrein [32], and
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generate vasoactive peptides (bradykinin, vasopressin, angiotensin, serotonin, and
prostaglandins) [33]. Many cleavage products are chemotactic for PMNs, fibroblasts,
and smooth muscle cells, thereby perpetuating the injury.
Additional characteristic features of bronchoalveolar lavage specimens from
patients with ARDS include increased amounts of inactivated, aggregated surfactant.
Studies by VonWichert and Kohl [34] have shown decreased dipalmitoylphosphatidyl
choline (major surface-active component of pulmonary surfactant)/phosphatidylcho-
line ratios among patients who died of ARDS. The extent to which this finding
accounts for alterations in lung elastic properties, increased critical airway closure, and
surface tension abnormalities favoring alveolar collapse is difficult to quantitate.
Compounding the problem of abnormal surfactant is the replacement of thin alveolar
epithelial Type I cells responsible for gas exchange by hyperplasia of thicker TypeII
cells [35].
Pulmonary Vascular Resistance
The magnitude of impairment of oxygen (02) and carbon dioxide (CO2) transfer
across alveolar-capillary membranes in ARDS, however, is not purely a function of
alterations in lung mechanics and shunt fraction alone. Shoemaker et al. [36] have
recently shown that patients with acute respiratory insufficiency display alterations in
direct and derived cardiovascular variables that may precede the clinical onset of
ARDS by as much as 36 hours. In the face of decreased arterial 02 content, cardiac
performance is increased as determined by thermodilution cardiac output and indices
of right and left ventricular stroke work. Mean pulmonary artery pressure and
pulmonary vascular resistance are usually markedly elevated. Peripheral oxygenation
is impaired, as a function of decreased blood hemoglobin and maldistribution of
microcirculatory perfusion causing increased tissue shunting. If mixed venous blood
has an oxygen tension below 30 mm Hg, this condition will compound arterial
hypoxemia [37].
The pulmonary hypertension seen in acute lung injury occurs on a multifactorial
basis. Pulmonary vascular resistance (PVR) may be altered passively, with the length
and radius of pulmonary blood vessels changing as a function of the mechanical and
elastic properties of the lung, or directly by the action of neurohumoral or chemical
mediators on vasomotor tone of the vascular smooth muscle [38]. Total PVR is
increased when lung volume is either decreased or increased from a normal functional
residual capacity [39]. At low lung volume, elastic recoil and relatively increased
interstitial fluid pressures shorten large (extra-alveolar) vessels in the lung and
increase resistance to flow through them. As lung volume increases, extra-alveolar
vessels lengthen and resistance decreases. At high lung volumes, extra-alveolar
resistance is minimal, but the resistance across the alveolar capillary bed increases
exponentially as alveolar capillaries are mechanically compressed and lengthened.
PVR, which is the net sum of the series resistances of extra-alveolar and alveolar
circulation, increases with increasing total lung capacity (Fig. 5).
The modulation of the pulmonary microcirculation by alveolar hypoxia may
contribute significantly to the onset of pulmonary hypertension during acute respira-
tory failure. Altering the distribution and the flow ofblood toward alveolar units which
are well ventilated and away from those that are not well ventilated maximizes VA/Q
matching and minimizes Qs/Q. Benumof et al. [40,41] have recently shown that
alveolar hypoxia increases pulmonary vascular resistance in the extra-alveolar circula-
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tion primarily and have postulated hypoxic pulmonary vasoconstriction (HPV) [42] as
a mechanism for increased PVR during ventilation at low lung volumes. Other studies
indicate that this effect occurs in both isolated lung [43] and intact animal models
[44], suggesting that HPV is primarily a response to local chemical stimuli, 02 and pH,
which are modulated by sympathetic vasomotor tone.
The autoregulation of the pulmonary microcirculation by HPV is impaired by
various factors, many ofwhich also may have profound effects on arterial oxygenation
[45] (Table 3). Acid-base disturbances can inhibit HPV. Metabolic and respiratory
alkalosis cause pulmonary vascular smooth muscle dilatation, whereas metabolic and
respiratory acidosis cause pulmonary vascular smooth muscle constriction. Mixed
venous oxygen tension may affect HPV, with a low mixed venous oxygen tension
causing pulmonary vascular vasodilation in acinar units. Furthermore, vasoactive
drugs that act directly on the pulmonary circulation may facilitate VA/Q mismatch by
inhibition of HPV. Vasodilators which inhibit HPV include sodium nitroprusside
[46,47], nitroglycerin [48], calcium channel blockers (diltiazem [49] and nifedipine
[50]), aminophylline, and aerosolized (alupent and terbutaline) and non-aerosolized
(isoproterenol and dobutamine) B2 agonists.
Anesthetic agents have variable effects on the pulmonary circulation. Inhalation
agents reported to inhibit HPV include nitrous oxide [51], isoflurane [52], and
halothane [53]. Intravenous induction and maintenance agents, by contrast, have
negligible effects on alveolar capillary microcirculation.
Clinical conditions ofacute and chronic left ventricular dysfunction such as dilated
cardiomyopathy, mitral insufficiency, or stenosis may inhibit HPV due to the inability
of the pulmonary microcirculation to constrict against pulmonary artery pressures
greater than 18 mm Hg [54].
Mediators ofLungInjury [21
One major substrate for proteolytic, chemotactic, and vasoactive mediators in
ARDS is arachidonic acid (Fig. 6). In its natural state, arachidonic acid is bound to
membrane phospholipids ofendothelial cells. In conditions ofgram-negative sepsis and
endotoxic shock, granulocytes in the presence of complement-activated plasma and
superoxide radicals (62-) stimulate membrane phospholipase to produce free arachi-THE ADULT RESPIRATORY DISTRESS SYNDROME
TABLE 3
Inhibitors of Hypoxic
Vasoconstriction (HPV)
Anesthetics
Halothane
Isoflurane
Nitrous oxide
Bronchodilators (B2)
Alupent
Aminophylline
Terbutaline
Calcium antagonists
Diltiazem
Nifedipine
Verapamila
Inotropes (B, and B2)
Amirinonea
Dobutamine
Isoproterenol
Mechanics
Cardiomyopathy
LV dysfunction
Mitral stenosis
Pulmonary hypertension
Metabolic states
Decreased PV02
Hypoxemia
Metabolic alkalosis
Respiratory alkalosis
Vasodilators
Nitroglycerin
Sodium nitroprusside
aProbable
donic acid [55]. Arachidonic acid is metabolized via the lipoxygenase pathway to
produce leukotrienes, the slow-reacting substance ofanaphylaxis (SRS-A), and 5- and
1 1-hydroxyeicosatetraenoic acid (5-HETE and 11-HETE), which are potent effectors
of increased lung vascular permeability and smooth muscle vascular resistance.
Matthay et al. [56] have identified very high levels of leukotriene D4(LTD4) in the
pulmonary edema fluid ofpatients with ARDS.
Alternatively, by the cyclo-oxygenase pathway, arachidonic acid is metabolized to
prostacyclin (PgI2) and thromboxane B2(TxB2), potent vascular smooth muscle
vasodilators, and to thromboxane A2(TxA2), which produces both potent bronchocon-
striction and pulmonary arteryvasoconstriction. Frolich et al. [57] have shown that the
pulmonary hypertension and increased airway resistance noted during endotoxemia is
a direct function of the endogenous production of TxA2. Furthermore, Gerber et al.
[58] have suggested that the loss ofHPV and subsequent pulmonary venous admixture
(QslQt) are secondary to the vasodilating action ofprostacyclin.
Some evidence supports the role of platelet aggregation and degranulation along
with fibrin deposition as a causative factor for lung microvascular injury and
small-vessel capillary occlusion [59]. In ARDS, the activation of the alternate
complement pathway is associated with increased circulating levels of C5a [60-62],
which has been shown to produce leukocyte and thrombocyte aggregation and fibrin
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deposition. The current concept is that activated PMNs aggregate, attach to the
pulmonary capillary endothelium, and release proteases and oxidants, thereby causing
endothelial damage [2]. Platelet degranulation results in the release of histamine and
serotonin, which produce smooth muscle vasoconstriction in pulmonary arterioles and
bronchioles [63]. In addition, platelet degranulation can activate the kallikrein system.
There is diffuse microthrombosis, reflecting increased local intravascular coagula-
tion.
Saba and Jafta [64] have shown low levels of plasma fibronectin (opsonic a2
endothelial surface binding protein) in sepsis and multiple organ failure. There is some
recent evidence to suggest that fibronectin may also be important in the repair of
vascular endothelial injury and may influence the clearance of vasoactive mediators
through the reticuloendothelial system.
MANAGEMENT OF ARDS
Mechanical Ventilation
The treatment ofARDS is largely supportive. Increases in extravascular lung water
decrease the elastic recoil properties of the lung due to increased alveolar and
interstitial pressures and altered alveolar surface tension forces. Thus, decreases in
lung compliance lead to marked alterations in pulmonary mechanics with an increased
work of breathing, to the extent that 20 percent of the total cardiac output may be
necessary for the energy requirements ofthediaphragm and intercostal musclesduring
spontaneous ventilation [65,66]. The tidal volumes of normal spontaneous ventilation
are well above critical closing volumes. In patients with ARDS, progressively greater
transpulmonary pressures are required to maintain alveolar ventilation. Total lung
volume is decreased. FRC and expiratory lung volume decrease and fall below critical
closing volumes, resulting in alveolar collapse. Because critical closing pressures in the
lung are usually significantly less than critical opening pressures, it takes more work to
re-expandcollapsed alveoli than tomaintain their patency, especiallyin thepresenceof
abnormal surfactant. In ARDS, decreased lung compliance favors progressive atelec-
tasis with resultant increases in QslQt. Since the basic abnormalities are both alveolar
flooding and alveolar collapse, increasing the inspired oxygen concentration (FI02)
does little to increase the oxygen content ofshunted pulmonary arterial blood through
non-ventilated alveoli.
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Reasonable guidelines for the institution ofmechanical ventilation may be based on
arterial blood gas measurements. The following determinants [67] indicate cardiore-
spiratory failure which, under most circumstances, is unable to meet systemic
metabolic demands:
1. PaO2 < 55 mm Hg on FIO2, 2 .5
2. PaCO2 2- 50 mm Hg
3. pH s 7.30
Intermittent positive-pressure ventilation has been employed successfully to reduce
theworkofbreathing and to improve arterial oxygenation since 1909 [68]. Thecurrent
practice of employing large tidal volumes (10-15 cc/kg) over long inspiratory times
(1.0-2.0 seconds) has afforded the re-expansion of collapsed alveoli and increased
functional residual capacity at modest inspiratory pressures [69]. The importanceofa
large tidal volume administration over a long inspiratory time is ofkey importance in
the ARDS lung, which has an average compliance of 20-30 cc/cm H20 (normal
ventilated lung is 50-100 cc/cm H20) and minimal risk of alveolar gas trapping.
Prolonged inspiratory times or inspiratory hold modes allow time for gas distribution
and pressure equalization in the lung and improve alveolar ventilation when airway
resistance is increased. The optimal inflation hold period for ARDS lung is about
.5-1.0 second and should be used in conjunction with inspiratory/expiratory ratios
(I:E) of 1:2 to 1:3 [70,71].
Additionally, some data support the use of a sine-wave pattern over a square-wave
flow pattern foroptimal ventilation in patients with ARDS [70]. Studies by Dammann
and McAshlan [71] have shown optimal inert (argon) gas distribution and minimal
VA/Q mismatching in ARDS patients during sine-wave-generated patterns ofventila-
tion. Noncompliant, inelastic lung produces high impedance to inspiratory gas flow
[72]. Lung inflation, therefore, is associated with nonhomogeneous gas distribution,
owing todifferences in pulmonary time constants (T = R x C) in the alveolar subunits
[73]. Consequently, convective gas flow is stratified into fast space (low resistance)
[74] and slow space (high resistance) [75] distribution throughout alveolar subunits.
The inhomogeneity of alveolar gas distribution is further stratified with increasing
rates of inspiratory flow. Positive-pressure ventilation at high frequency and short
inspiratory phase produces great differences between fast and slow space ventilation
and is the primary mechanism for mechanical ventilation-induced VA/Q mismatch
[76].
The inspiratory plateau of the ventilatory cycle is designed as an equilibrium,
non-dynamic state during which pressure and flow become constant within the alveoli.
By allowing the distribution ofinspired gas from fast to slow spaces, a penduluft effect
is created which improves ventilation to the low compliance subunits [77]. Pressure
redistribution in the lung results in an alveolar recruitment phase during the
end-inspiratory plateau [78]. Because pressure becomes constant during the inspira-
tory hold, total chest compliance (CT) may be approximated from the change in
exhaled lung volume and the change in airway pressure:
CT = VT (PEI - PB)
where VT = exhaled tidal volume
PEI = end-inspiratory pressure
PB= baseline airway pressure
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Theexpiratory phaseofa mechanically ventilated breath for a patientwith ARDS is
generally a passive return to baseline (atmospheric) pressure. The rate of this decline
in pressure is determined by the elastic recoil forces ofthe lung. Expiratory resistance
may be applied to retard flow and splint small airways to prevent premature alveolar
closure. This might best bedone in thesetting ofpatients receiving low-rate, largetidal
volume ventilation to minimize problems with gas trapping in the lung and pulmonary
barotrauma.
In ARDS, therefore, there is a rationale for the use oflarge volume (15 cc/kg) and
low-frequency ventilation with an emphasis toward increased I:E ratios (slow inspira-
tory flow rates) to facilitate maximal inspired gas distribution at lower peak airway
pressures.
Positive End-Expiratory Pressure
Despite modifications of inspiratory and expiratory flow patterns, alveolar collapse
following mechanical inspiration occurs as end-expiratory pressure falls below critical
closing pressure, creating respiratory-phasic increases in Qs/Qt. The application of
positive end-expiratory pressure (PEEP) [79-82] at a pressure which exceeds critical
closing pressure minimizes atelectasis, increases FRC, and decreases Qs/Qt. In ideal
terms, the inspiratory phase of mechanical ventilation should inflate atelectatic lung
while PEEP should prevent the re-establishment ofQs/Qt.
The physiologic goal of PEEP therapy is to increase functional residual capacity so
that alveoli remain open throughout all phases of the respiratory cycle to participate
continually in gas exchange. This state allows optimization of systemic oxygen
transport at relatively lower inspired oxygen concentrations in an effort to minimize
the risk of oxygen toxicity. PEEP increases functional residual capacity in a linear
relationship in normal lungs [83], usually at a rate of 400 cc/5 cm H20 positive
end-expiratory pressure [84]. The usual therapeutic range for PEEP is 0-15 cm H20;
some investigators have used higher levelsofPEEP (25-42 cm H20) [85]. Controversy
has surrounded the definition ofoptimal PEEP. Suter et al. [86] defined "best PEEP"
as the point ofmaximal static lung compliance, whereas "optimal PEEP" refers to the
PEEP level which reduces Qs/Qt to 15 percent while maintaining satisfactory
cardiovascular function [87].
In general, there are no specific guidelines for PEEP administration. Under most
conditions, PEEP in 3-5 cm H20 increments will significantly reduce Qs/Qt and
improve systemic oxygen transport. Under optimal conditions, the inspired fraction of
oxygen should be decreased to .5 or less on PEEP settings of up to 15-18 cm H20.
Civetta et al. [88] have shown recently that a significant number of patients with
ARDS require PEEP at levels above 15 cm H20 and have advocated the use of PEEP
at levels only to be limited by decreased systemic oxygen transport. Since PEEP may
profoundly depress cardiac function and overdistend normal alveoli, hence decreasing
alveolar blood flow, too much PEEP will decrease overall systemic oxygen transport.
Furthermore, PEEP has been shown to increase pulmonary artery pressure at about
one-third to one-halfthe rate ofincrease in transpulmonary pressure [89]. Some ofthe
extravascular lung water is redistributed from the airspaces to the lung interstitium,
but PEEP does not reduce the overall lung water. Actually, data support an increase in
extravascular lung water with PEEP therapy, probably on the basis ofaltered effluent
lymphatic flow [90]. Because of the redistribution and net increase in extravascular
lung water, the abrupt discontinuation of PEEP may lead to rebound alveolar flooding
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and acute increases in Qs/Qt. Guidelines for PEEP discontinuation, therefore, should
favor a gradual wean ofpositive end-expiratory pressure at a rate not to exceed 3-5 cm
H20 per 12 hours when discontinuing mechanical ventilatory support [91].
A recent prospective study by Pepe et al. [92] established that PEEP does not have
prophylactic value in preventing ARDS in high-risk patients.
Oxygen Therapy and Oxygen Toxicity
Increases in inspired oxygen concentration (FI02) will usually improve arterial
oxygenation. Arterial hypoxemia is often secondary to low but finite VA/Q ratios in the
lung. The arterial hypoxemia produced by low VA/Q is worsened by low F102 and
improved by increasing F102. In ARDS, the cause for arterial hypoxemia is increased
QslQt primarily, and only to a small extent caused by low VA/Q ratios. Theapplication
of hyperoxic therapy, therefore, is often of very little value in fixed shunt conditions.
Despite significant evidence to the contrary, high inspired oxygen is still commonly
used in the treatment of acute respiratory failure.
Although in the immediate term hyperoxic therapy is partially effective in altering
arterial hypoxemia, prolonged exposure to elevated partial pressures of oxygen is
associated with lung microvascular and cellular injury. The histopathology of oxygen
toxicity is indistinguishable from that of ARDS, making the limitations of oxygen
therapy difficult to define. The final outcome is progressive interstitial fibrosis and
destruction of pulmonary architecture.
The mechanisms of oxygen toxicity involve single electron transfers to molecular
oxygen which produce three major cytotoxic molecules: superoxide anion, hydrogen
peroxide, and hydroxyl radicals. Superoxide (02-) is reactive in cellular pathways and
may function both as an oxidant by obtaining electrons or as a reductant by giving up
its unpaired electron to produce molecular oxygen (02) in a more stable low-energy
state. The hydroxyl radical (OH-) is the most reactive and cytotoxic intermediate. It is
largely generated from 2- by the Fenton reaction with iron.
The biochemical pathways ofoxygen toxicity remain to be fully elucidated [93-98].
Significant data link the activity of these oxygen intermediates to the breakdown of
cellular membrane lipids, a process which is called lipid peroxidation. Lipid peroxides
produced by this process are inhibitors of cellular enzyme function. Nucleic acid and
cellular protein destruction occur via sulfhydryl oxidation mediated by these high-
energy oxygen moieties.
In normal lung, sufficient protective mechanisms exist to maintain a constant
clearance of these free oxygen radicals. Cytochrome oxidase plays a major role in the
multivalent reduction of oxygen radicals and compartmentalizes free electrons within
the mitochondria so that they cannot interact with cellular proteins. Further specific
enzymatic pathways break down these intermediates. Superoxide dismutase converts
superoxide anion to hydrogen peroxide, which is then catalyzed to water and oxygen.
Additionally, glutathione peroxidases will directly reduce hydrogen peroxide (H202).
Lastly, glutathione by itselfis an effective free radical scavenger.
The antioxidant pathways are very effective at normal fractions of inspired oxygen
at normal atmospheric pressure. Kinetic studies show that the rate of oxygen radical
production equals the rate of clearance. In ARDS, activated granulocytes in the
presence of increased F102 enhance superoxide radical formation [93]. Flick and
others [94] have shown decreased superoxide dismutase activity in sepsis and
microembolic states. Reversible functional changes have also been observed in alveolar
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macrophagic function with a 60 percent decrease in foreign particle clearance in lung
exposed to 100 percent oxygen for 48 hours [95]. Furthermore, increased oxygen
tensions (90-95 percent) have been shown to reduce mucociliary transportduring lung
injury from mean rates of 23 mm/minute to 10 mm/minute after a six-hour exposure
[96].
Certain conditions may predispose to oxygen toxicity. Both paraquat [97] and
bleomycin [2] enhance the rate of free oxygen radical generation in injured lung and
increase the development ofpulmonary interstitial fibrosis.
A spectrum of clinical observations has been made in normal volunteers breathing
100 percent oxygen. During the first six hours, respiratory function and ventilation
remain normal, and tracheobronchitis is found to occur [99]. Between six and 24 hours
of exposure, ventilatory mechanics are impaired, marked by increased splinting and
reduction in vital capacity [100]. After 24 to 30 hours of exposure, increases in
extravascular lung water and decreases in total thoracic compliance are noted, along
with gas exchange abnormalities of low PaO2 and increased A-a02 difference [101].
After 72 hours, a gradual decrease in diffusion capacity is demonstrated. This clinical
spectrum is reversible over a two-week period.
Absorption Atelectasis
High fractional inspired oxygen concentrations lead to absorption atelectasis. At an
F102 of .5 or less, nitrogen comprises much of the total alveolar gas pressure. Since
nitrogen exists fully saturated in body fluids and tissues, only oxygen is transferred
from the alveolus to blood, and a net transfer of nitrogen does not occur. Nitrogen is
therefore retained in the alveolus and serves as a "splint" as the entire gas volume of
oxygen diffuses into blood. At increasing inspired concentrations ofoxygen, decreasing
amounts of residual gas remain in alveoli, and progressive atelectasis may occur in
mechanically ventilated patients at an F102 of 1.0 after 24 hours (Fig. 7) [102]. In
general, the magnitude of absorption atelectasis is directly proportional to the blood
solubility of the inspired gas mixture [103]. Under general anesthesia with 75:25
percent nitrous oxide (N20):oxygen mixture of inspired gas, atelectasis is likely to
occur as N20 diffuses into the blood at a rate which is 34-fold that ofnitrogen:oxygen
mixtures at normal atmospheric pressure [104].
Pulmonary Barotrauma
Pulmonary barotrauma refers tothedevelopment ofpneumothorax, pneumomedias-
tinum, or subcutaneous emphysema due to the rupture of alveoli with gas dissection
along blood vessels and fascial planes. The overall incidence ofpulmonary barotrauma
in ARDS patients being mechanically ventilated is about 7 percent. Highest incidences
have been reported among patients with chronicobstructive bronchitis andemphysema
with an increased tendency to gas trapping. Special procedures such as bronchoscopy
and central line placement further increasethis risk. Theaddition ofPEEPup to 15 cm
H20 does not alter this incidence significantly. In patients who require PEEP levels of
25-40 cm H20 the incidence ofpulmonary barotrauma increases to about 14 percent,
but what remains difficult to determine is to what degree this effect is due to PEEP and
mechanical ventilation or to the intrinsic lung disease itself.
To summarize, arterial hypoxemia requires aggressive positive-pressure ventilation
directed to minimize Qs/Qt in order to achieve an arterial oxygen saturation of 90
percent on an F102 of .5 or less. Mostoften this can be achieved with PEEP levels of 15
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cm H20 or less, but there are no arbitrary limits, and selected patients may require
very high-level PEEP (20-40 cm H20) to achieve oxygenation in spite ofthe attendant
risks of alveolar rupture and pulmonary barotrauma. In all instances, the effect of
PEEP should be determined so that tissue oxygen delivery remains optimal.
Heart-Lung Interaction
As early as 1947, Cournand et al. [1051 demonstrated that intermittent positive-
pressure ventilation with PEEP decreases cardiac output in man. Braunwald [106]
subsequently has shown the relationship between transthoracic and transpulmonary
pressure gradients developed during mechanical ventilation and the translocation of
central blood volume peripherally leading to decreased venous return [106]. Further-
more, this effect was reversed by aramine infusions and pronounced by conditions of
hypovolemia and decreased systemic vascular resistance [107]. Right and left ventric-
ular chamber studies [108-110] suggested that decreases in cardiac output had a
multifactorial basis which included:
1. Decreased venous return
2. Increased right heart afterload and right heart dysfunction
3. Decreased biventricular preload
4. Altered cardiac geometry and contractile symmetry
5. Altered right and left ventricular interdependence
6. Decreased contractility
The output of the right ventricle is significantly afterload-dependent [111]. Princi-
pal ventilatory factors determining right heart afterload include airway pressure and
resting lung volume. Total pulmonary vascular resistance is increased when lung
volume is either decreased or increased from a normal functional residual capacity.
Increases in transpulmonary pressure during mechanical ventilation increase lung
volume and may exponentially increase pulmonary vascular resistance. Changes in
ventilatory phaseormode may modulate right heart hemodynamics byincreasing right
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ventricular afterload. Right ventricular failure in combination with decreased venous
return may synergistically depress cardiac output.
The relationship between pulmonary vascular resistance and total cardiac blood
flow is a hyperbolic function with cardiac output decreasing exponentially with
increased pulmonary vascular resistance [112]. Jardin et al. [113] have shown that
mechanical ventilation with PEEP (30 cm H20) and volume loading (10 cc/kg) can
result in a shift of the interventricular septum with paradoxical motion due to right
heart dilatation, and decreased left ventricular chamber size. In pericardiectomized
patients, thisseptal interactionmay beminimized, as the free wall ofthe right ventricle
may be displaced laterally, and left ventricular function may be less impaired by
changes in right heart mechanics [114]. Right ventricular impairment and leftward
septaldisplacement also cause alterations in left ventricular pressure-volume relation-
ships in dogs and support a theoretical basis for ventilation and PEEP effects on left
ventricular filling and diastolic function [115]. Augmented right ventricular loading
can significantly affect left ventricular performance.
Because the right ventricle is a low-pressure chamber with systolic function
primarily afterload-dependent, changes in right ventricular hemodynamics may be a
marker for the potential impairment of left ventricular function during mechanical
ventilation. Until recently, methods of evaluating right ventricular function were
limited to angiographic, radionuclide (Technetium 99M, both first-pass and gated
studies), and echocardiographic techniques. Inherent in these techniques were prob-
lems in imaging the right ventricle due to its crescent-shaped geometry, coaxial
shortening, and location under the sternum.
Recent advances in the design of thermistors for pulmonary artery catheters allow
for the continuous andrepeated measurement ofright ventricular ejection fraction in a
simple and accurate manner. The response time ofthe thermistor has been modified to
50 msec, which is rapid enough to measure beat-to-beat temperature variations and
allow forcalculation ofrightventricularejection fraction via thermal indicator dilution
methods [116].
Right ventricular ejection fraction is defined as right ventricular stroke volume
divided by right ventricular end-diastolic volume. The normal value for right ventricu-
lar ejection fraction obtained via this thermal technique is approximately 40 percent
[117].
The reproducibility, accuracy, and clinical applicability of this technique were
demonstrated in both a canine model and humans following cardiac surgery. Injection
of the thermal indicator just above the tricuspid valve was associated with a high
reproducibility (r = 0.90) as well as accuracy (r = 0.90) [117].
New data have shown that in post-operative ventilated patients thermal right
ventricular ejection fraction deteriorates (45 percent to 27 percent) with PEEP levels
greater than 15 cm H20. This is associated with a concomitant increase in right
ventricular end-diastolic volume and right ventricular end-systolic volume (Fig. 8)
[118]. Changes in ventilatory phase or mode may modulate right heart function, as
right ventricular ejection fraction is most reduced with assist control ventilation (29
percent) and increased with increasing levels of negative inspiration during intermit-
tentmandatory (42percent) andspontaneous (49 percent) ventilation (Fig. 9). This is
supported by observations that cardiac output in mechanically ventilated ARDS
patients was affected by an average PEEP of 22 cm H20 during intermittent
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FIG. 8. Data showing the effect of PEEP on thermal right ventricular ejection
fraction (RVEF), right ventricular end-diastolicvolume (RVEDV), and right ventricu-
lar end-systolic volume (RVESV).
mandatory versus an average PEEP of 11 cm during assist control ventilation, which
directly correlated with changes in intrathoracic pressure between modes [119].
The interdependence ofcardiopulmonary function during acute respiratory distress
provides an important indication for the use of pulmonary artery catheterization for
the analysis of direct and derived hemodynamic indices (Table 4). Packman and
Rackow [120] have suggested an optimal PCWP range of 8-12 cm H20 in patients in
shock with acute respiratory failure to maintain both cardiac output and to minimize
extravascular lung water. Barash [121] has advocated the use of the left ventricular
stroke work index and pulmonary capillary wedge pressure to assess overall cardiac
performance during mechanical ventilation. By plotting left ventricular stroke work
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TABLE 4
Hemodynamic Variables
Variable Circulation Normal Range
Cardiac index (CI)
Stroke volume index (SVI)
Systemic vascular
resistance index (SVRI)
Pulmonary vascular
resistance index (PVRI)
Left ventricular stroke work index
(LVSWI)
Right ventricular stroke work index
(RVSWI)
Right ventricular ejection fraction
(RVEF)
Right ventricular end-diastolic vol-
ume index (RVEDVI)
Right ventricular end-systolic vol-
ume index (RVESVI)
Arterial 02 content (CaO2)
Mixed venous 02 content (CvO2)
Pulmonary capillary 02 content
(CcO2)
Oxygen transport (SOT)
Oxygen consumption (VO2)
A-V 02 difference (A-V O2D)
Intrapulmonary shunt (Qs/Q,)
CI = CO/BSA
SVI = CI/HR
SVRI =80 (MAP - RAP)/CI
PVRI = 80 (MPAP - PCWP)/CI
LVSWI = 0.0136 (MAP -
CVP)SVI
RVSWI = 0.0136 (MPAP -
PCWP)SVI
RVEF = SV/EDV
RVEDVI = SVI/EF
RVESVI = RVEDVI - SVI
CaO2 = (1.39 . Hb * O2Sat) +
(PaO2. 0.0031)
CvO2 - (1.39 . Hb * O2VSat) +
(PvO2 * 0.0031)
CcO2 - (1.39 . Hb. 1) +
(PAO2- 0.0031)
SOT = CO * CaO2
- 10
V02 (CaO2 - CvO2) - CO. 10
A-V 02D = CaO2 - CvO2
Qst/Qt = (CcO2 - CaO2)/
(CCO2 - CV02)
2.5-4.0 1/minute/M2
30-50 ml/beat/m2
1,800-2,500 dynes/second
cm5/m2
50-220 dynes/second
cm5/m2
44-68 g/m/beat/m2
4-8 g/m/beat/m2
40-50%
80-120cc/M2
50-70 cc/M2
18-20 vol%
13-16 vol%
21 vol%
800-1,200 ml/minute
180-320 ml/minute
4-6 vol%
s<8%
Abbreviations: CO = cardiac output, BSA = body surface area, 02 = oxygen, PaO2 - alveolar oxygen
tension
index as a function ofpulmonary capillary wedge pressure, it is possible to construct a
ventricular function curve. This curve represents the total work within a given cardiac
cycle. An upward shift of the curve (as with volume loading) denotes improved
ventricular performance, and a downward shift ofthe curve (as with increased PEEP)
denotes impaired ventricular performance.
Optimizing systemic oxygen transport in acute hypoxic respiratory failure requires
diligent use of direct and derived hemodynamic data. Recent work by Malloy et al.
[122] suggested that systemic oxygen delivery might best be optimized by inotropic
agents such as dobutamine, which increase cardiac output and concomitantly decrease
pulmonary capillary wedge pressure, instead ofmore classically utilized dopamine. In
eight patients, dobutamine increased indices ofcardiac function as noted by increased
left ventricular ejection fraction, decreased left ventricular volume, and increased
cardiac output, and favorably influenced respiratory function as noted by increased
arterial oxygen tension and decreased Qs/Qt during PEEP.
The interfaced physiologyofthe heart and lungs in patients with ARDS requires the
use of derived respiratory indices (refer to Table 4), specifically systemic oxygen
transport, to define optimal levels of artificial respiratory support. Mixed venous
oxygen tension (Pv02), likewise, represents the final balance between tissue oxygen
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supply and demand and makes possible thedetermination ofoverall oxygen uptakeand
utilization.
SUMMARY
Despite the ubiquitous use of advanced hemodynamic and ventilatory support, it is
estimated that 40,000 patients with ARDS will die annually. Overall mortality rates
approach 60-70 percent, with a significantly worse prognosis for ARDS combined
with multi-organ systems failure. Although one might expect physiological parame-
ters, such as arterial oxygen tension, A-a gradient, and lung compliance, to be
somewhat predictive of outcome, there are no statistical differences in outcome
between survivors and non-survivors in these parameters [123]. Therapeutic interven-
tions, including extracorporeal support of the circulation, have similarly failed to
influence these statistics. With recent advances in cardiopulmonary supportive care,
we remain hopeful for a better understanding of the basic mechanisms of lung injury
and repair, the better to guide therapeutic options.
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